Stocks making the biggest premarket moves: Metsera, Compass, Kenvue, Fox & more
See which stocks are posting big moves before the bell.
Dan Ives raises Apple price target to highest on Wall Street, cites strong iPhone 17 demand
Ives’ new target signals upside of more than 25% for the tech giant.
Build-A-Bear Workshop is a bright spot in retail even with tariffs, dwindling mall traffic
Even as the retail industry faces headwinds, Build-A-Bear Workshop is riding on its momentum borne out of nostalgia, legacy branding and diversifying.
Family offices are still keen on direct deals but retreat from startup, early-stage investing
Seven out of 10 family offices make direct investments in private companies, and nearly half of them doubled down in 2025, per a new Citi survey.
Pfizer to buy weight-loss drug developer Metsera in $7.3 billion deal
Pfizer said on Monday it would acquire weight-loss drug developer Metsera in a deal valued up to $7.3 billion.
Trump’s $100,000 H-1B fee sparks a global race to grab top talent
The six-figure H-1B visa fee has jolted companies that have long relied on the program to bring in top global talent.
Club nation: Why Costco, Sam’s Club and BJ’s are opening new stores and gaining members
Club retailers have drawn in shoppers with faster online options, eye-catching merchandise and cheap meals along with low-priced and bulk items.
How India will feel the sting of Trump’s H-1B visa fee hike
Investors shed shares of IT outsourcing firms of all sizes, including Infosys, Tech Mahindra, Wipro, HCL Technologies and Tata Consultancy Services.
Europe markets set for mixed open as investors assess Trump’s visa crackdown
European stocks were set to open mixed on Monday morning.
Europe’s IPO uptick sparks hopes of a much needed rebound
After a sluggish period for public listings in Europe, a slew of companies have either recently floated or are rumored to be eyeing an IPO in the region.